Journal
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Volume 54, Issue -, Pages S33-S43Publisher
WILEY
DOI: 10.1111/apt.16597
Keywords
-
Funding
- Ironwood Pharmaceuticals
Ask authors/readers for more resources
The diagnosis and investigation of irritable bowel syndrome (IBS) should be based on clinical assessment of symptoms to avoid unnecessary and costly tests. It is important to focus on making a positive diagnosis and consider specific tests, such as serological testing for coeliac disease or faecal calprotectin, based on the patient's presentation. The adoption of a standardized approach to diagnosis and investigation will promote high-quality care for patients with suspected IBS.
Irritable bowel syndrome (IBS) is a common disorder of gut-brain interaction. It is defined by the Rome criteria as the presence of abdominal pain, related to defaecation, associated with a change in stool form and/or frequency. The approach to diagnosis and investigation of suspected IBS varies between clinicians and, due in part to the uncertainty that can surround the diagnosis, many still consider it to be a diagnosis of exclusion. However, exhaustive investigation is both unnecessary and costly, and may also be counterproductive. Instead, physicians should aim to make a positive diagnosis, based on their clinical assessment of symptoms, and limit their use of investigations. The yield of routine blood tests in suspected IBS is low overall, but normal inflammatory markers may be reassuring. All patients should have serological testing for coeliac disease, irrespective of their predominant stool form. Routine testing of stool microbiology or faecal elastase is unnecessary; however, all patients with diarrhoea aged <45 should have a faecal calprotectin or a similar marker measured which, if positive, should lead to colonoscopy to exclude possible inflammatory bowel disease. Colonoscopy should also be undertaken in any patient reporting alarm symptoms suggestive of colorectal cancer, and in those whose presentation raises suspicion for microscopic colitis. Testing for bile acid diarrhoea should be considered for patients with IBS with diarrhoea where available. Hydrogen breath tests for lactose malabsorption or small intestinal bacterial overgrowth have no role in the routine assessment of suspected IBS. Adopting a standardised approach to the diagnosis and investigation of IBS will help to promote high-quality and high-value care for patients overall.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available